Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68.64 USD | +0.04% |
|
-2.95% | -15.27% |
07-01 | HOOKIPA Pharma Reports First Patient Dosed in HIV Treatment Study | MT |
07-01 | HOOKIPA Pharma Inc. Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.27% | 85.52B | |
+56.86% | 823B | |
+44.59% | 641B | |
-6.57% | 352B | |
+17.32% | 324B | |
+9.94% | 301B | |
+15.72% | 241B | |
+1.27% | 223B | |
+12.74% | 218B | |
+7.98% | 167B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- BMO Capital Adjusts Price Target on Gilead Sciences to $80 From $89